3/29/2021 3:43:02 AM
Merck KGaA Announces Commercial Launch Of LicriOn Solution
3/18/2021 8:13:47 AM
Exelixis Enters Clinical Trial Collaboration And Supply Agreement With Merck KGaA And Pfizer
3/16/2021 3:41:34 AM
Merck KGaA Reports Topline Data For Bintrafusp Alfa As Second-Line Monotherapy Treatment In Biliary Tract Cancer
3/10/2021 2:19:28 AM
Merck KGaA Announces Commercial Launch Of Eyrise I350 Invisible Privacy Glazing
3/9/2021 9:12:53 AM
Genome Signs Second Trial Collaboration And Supply Deal With Merck KGaA, And Pfizer For Immuno-oncology Microbiome Study
3/4/2021 1:01:48 AM
Merck KGaA FY Sales Increase By 8.6% To EUR 17.5 Bln
2/25/2021 6:48:13 AM
Merck KGaA To Provide Biologics Contract Development Services Through BioReliance Solutions
2/15/2021 8:52:03 AM
Merck KGaA Launches An Enhanced Design For Sustainability Framework
2/9/2021 8:14:43 AM
Merck KGaA Announces Investment Of EUR 18 Mln At Its Site In Tempe, Arizona
1/25/2021 2:13:08 AM
Merck KGaA : EC Oks BAVENCIO For First-Line Maintenance Treatment Of Locally Advanced Or Metastatic Urothelial Carcinoma
1/20/2021 7:35:50 AM
Merck KGaA To Discontinue Bintrafusp Alfa Clinical Trial
1/14/2021 4:18:45 AM
Philips Announces Multi-year Partnership With Merck KGaA